Skip to main content
VCbacked
Log inGet Started

Storm Therapeutics

Cambridge, United Kingdom

Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.

$56.0M raised
Apr 2026
Series C
BiotechnologyHealth CareMedicalTherapeutics

Top Investors

Fast Track InitiativeInc.Taiho VenturesUTokyo Innovation PlatformIP GroupCambridge Innovation Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Storm Therapeutics

How much funding has Storm Therapeutics raised?
Storm Therapeutics has raised $56.0M in total funding. The most recent round was Series C. The last funding was announced in April 2026.
Who are Storm Therapeutics's investors?
Storm Therapeutics's investors include Fast Track Initiative, Inc., Taiho Ventures, UTokyo Innovation Platform, IP Group, Cambridge Innovation Capital.
Where is Storm Therapeutics headquartered?
Storm Therapeutics is headquartered in Cambridge, United Kingdom.
What does Storm Therapeutics do?
Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.
What stage is Storm Therapeutics at?
Storm Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Storm Therapeutics — Funding & Investors." VCBacked, April 16, 2026, https://www.vcbacked.co/company/storm-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Storm Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/storm-therapeutics
Wikipedia (cite web)
{{cite web |title=Storm Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/storm-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K